ID

29220

Beschrijving

Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00614120

Link

https://clinicaltrials.gov/show/NCT00614120

Trefwoorden

Versies (1)
  1. 08-03-18 08-03-18 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

8 maart 2018

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Diabetes NCT00614120

Engels

Eligibility Diabetes NCT00614120

1 Formulieren  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00614120
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes
Beschrijving

Diabetes Mellitus, Non-Insulin-Dependent

Datatype

boolean

Alias
UMLS CUI [1]
C0011860
subjects diagnosed with type 2 diabetes and treated with one or more oral antidiabetic drugs (oads) for the last 3 months
Beschrijving

Diabetes Mellitus, Non-Insulin-Dependent | Antidiabetics Oral Quantity

Datatype

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2,1]
C0935929
UMLS CUI [2,2]
C1527415
UMLS CUI [2,3]
C1265611
hba1c: 7.0-11.0% (both incl.) for subjects on oad alone
Beschrijving

Glucohemoglobin measurement | Antidiabetics Oral Alone

Datatype

boolean

Alias
UMLS CUI [1]
C0202054
UMLS CUI [2,1]
C0935929
UMLS CUI [2,2]
C1527415
UMLS CUI [2,3]
C0205171
hba1c: 7.0-10.0 % (both incl.) for subjects on oad combination therapy
Beschrijving

Glucohemoglobin measurement | Antidiabetics Oral | Combined Modality Therapy

Datatype

boolean

Alias
UMLS CUI [1]
C0202054
UMLS CUI [2,1]
C0935929
UMLS CUI [2,2]
C1527415
UMLS CUI [3]
C0009429
bmi less than 45.0 kg/m^2
Beschrijving

Body mass index

Datatype

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
treatment with insulin within the last 3 months prior to the trial
Beschrijving

Insulin regime

Datatype

boolean

Alias
UMLS CUI [1]
C0557978
impaired liver or/and renal function
Beschrijving

Liver Dysfunction | Renal Insufficiency

Datatype

boolean

Alias
UMLS CUI [1]
C0086565
UMLS CUI [2]
C1565489
significant cardiovascular disease over the last 6 months
Beschrijving

Cardiovascular Disease Disease length

Datatype

boolean

Alias
UMLS CUI [1,1]
C0007222
UMLS CUI [1,2]
C0872146
known retinopathy or maculopathy
Beschrijving

Retinal Disease | Disorder of macula of retina

Datatype

boolean

Alias
UMLS CUI [1]
C0035309
UMLS CUI [2]
C0730362
recurrent major hypoglycaemia or hypoglycaemic unawareness
Beschrijving

Recurrent severe hypoglycemia | Loss of hypoglycemic warning

Datatype

boolean

Alias
UMLS CUI [1]
C0342316
UMLS CUI [2]
C0342317
Terug naar het begin van de pagina

Similar models

Eligibility Diabetes NCT00614120

1 Formulieren
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00614120
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent | Antidiabetics Oral Quantity
Item
subjects diagnosed with type 2 diabetes and treated with one or more oral antidiabetic drugs (oads) for the last 3 months
boolean
C0011860 (UMLS CUI [1])
C0935929 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
Glucohemoglobin measurement | Antidiabetics Oral Alone
Item
hba1c: 7.0-11.0% (both incl.) for subjects on oad alone
boolean
C0202054 (UMLS CUI [1])
C0935929 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0205171 (UMLS CUI [2,3])
Glucohemoglobin measurement | Antidiabetics Oral | Combined Modality Therapy
Item
hba1c: 7.0-10.0 % (both incl.) for subjects on oad combination therapy
boolean
C0202054 (UMLS CUI [1])
C0935929 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0009429 (UMLS CUI [3])
Body mass index
Item
bmi less than 45.0 kg/m^2
boolean
C1305855 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Insulin regime
Item
treatment with insulin within the last 3 months prior to the trial
boolean
C0557978 (UMLS CUI [1])
Liver Dysfunction | Renal Insufficiency
Item
impaired liver or/and renal function
boolean
C0086565 (UMLS CUI [1])
C1565489 (UMLS CUI [2])
Cardiovascular Disease Disease length
Item
significant cardiovascular disease over the last 6 months
boolean
C0007222 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Retinal Disease | Disorder of macula of retina
Item
known retinopathy or maculopathy
boolean
C0035309 (UMLS CUI [1])
C0730362 (UMLS CUI [2])
Recurrent severe hypoglycemia | Loss of hypoglycemic warning
Item
recurrent major hypoglycaemia or hypoglycaemic unawareness
boolean
C0342316 (UMLS CUI [1])
C0342317 (UMLS CUI [2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial